Wanbury

Wanbury Dividend Coverage

Dividend Coverage Ratio of Wanbury (WANBURY.NS) as of Oct 18, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Wanbury is 2026 - . Dividend Coverage Ratio of Wanbury was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wanbury Stock analysis

What does Wanbury do? Wanbury Ltd is a pharmaceutical company headquartered in Navi Mumbai, India. It operates through two divisions: Active Pharmaceutical Ingredients (API) Business and Domestic Formulations Business. The API division produces Metformin for type 2 diabetes treatment and Sertraline as an antidepressant, among other products including Diphenhydramine, Mefenamic Acid, Glucosamine, Methoxsalen, and Paroxetine. The company employs 1,582 people and has an annual Metformin production capacity of over 8,500 tons. Wanbury has subsidiaries in the Netherlands, UAE, China, and Spain. Its IPO date was February 24, 1992. Wanbury is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wanbury stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Wanbury since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Wanbury historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Wanbury

All Key Metrics — Wanbury